CN Patent

CN114010575B — 新斯的明及其衍生物的新制剂

Assigned to Jiangsu Tieqi Pharmaceutical Technology Co ltd · Expires 2024-06-28 · 2y expired

What this patent protects

本发明提供了一种新斯的明及其衍生物的新制剂。所述制剂包括以新斯的明或者新斯的明衍生物为活性成分的舌下黏膜制剂、鼻黏膜制剂、直肠黏膜制剂、阴道及子宫黏膜制剂、口腔颊粘膜制剂。所述制剂通过口腔颊粘膜、舌下黏膜、鼻黏膜、直肠黏膜或者阴道及子宫黏膜中的任一种黏膜途径进行给药，在制备用于重症肌无力、手术后腹胀与尿潴留、室上性阵发性心动过速治疗以及筒箭毒碱过量时解毒的药物中具有极大的临床应用价值。

USPTO Abstract

本发明提供了一种新斯的明及其衍生物的新制剂。所述制剂包括以新斯的明或者新斯的明衍生物为活性成分的舌下黏膜制剂、鼻黏膜制剂、直肠黏膜制剂、阴道及子宫黏膜制剂、口腔颊粘膜制剂。所述制剂通过口腔颊粘膜、舌下黏膜、鼻黏膜、直肠黏膜或者阴道及子宫黏膜中的任一种黏膜途径进行给药，在制备用于重症肌无力、手术后腹胀与尿潴留、室上性阵发性心动过速治疗以及筒箭毒碱过量时解毒的药物中具有极大的临床应用价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN114010575B
Jurisdiction
CN
Classification
—
Expires
2024-06-28
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Tieqi Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.